Engineers Gate Manager LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1620220 NEW YORK, NY

Position in VIR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,243,503

+$1,957,584 QoQ

Shares Held

250,391

+341.4% QoQ

Ownership

0.148%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Engineers Gate Manager LP holds $239,656,316 across 145 Biotechnology names. VIR ranks #20 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	158,792	$25,965,667
2	BMRN	Biomarin Pharmaceutical Inc	436,860	$24,678,221
3	BBIO	BridgeBio Pharma, Inc.	243,729	$18,099,315
4	JAZZ	Jazz Pharmaceuticals plc	92,990	$17,579,759
5	ALNY	Alnylam Pharmaceuticals, Inc.	32,502	$10,753,936
6	IONS	Ionis Pharmaceuticals Inc	133,827	$10,049,069
7	TVTX	Travere Therapeutics, Inc.	254,401	$7,558,253
8	ROIV	Roivant Sciences Ltd.	256,447	$7,103,581

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,243,503	250,391	+341.4%	Shares	Sole	2026-05-15
2025-06-30	$285,919	56,730	-57.5%	Shares	Sole	2025-08-14
2025-03-31	$865,922	133,630	+176.7%	Shares	Sole	2025-05-15
2024-06-30	$429,816	48,294	+4.9%	Shares	Sole	2024-08-14
2024-03-31	$466,547	46,056	-39.9%	Shares	Sole	2024-05-15
2023-12-31	$770,314	76,572	+340.1%	Shares	Sole	2024-02-14
2023-09-30	$163,028	17,399	-72.1%	Shares	Sole	2023-11-14
2023-03-31	$1,452,978	62,440	+232.2%	Shares	Sole	2023-05-15
2022-12-31	$475,777	18,798	-68.8%	Shares	Sole	2023-02-14
2022-09-30	$1,161,157	60,226	+42.5%	Shares	Sole	2022-11-14
2022-06-30	$1,076,464	42,264	-13.3%	Shares	Sole	2022-08-15
2022-03-31	$1,253,464	48,735	+43.9%	Shares	Sole	2022-05-16
2021-09-30	$1,473,761	33,864	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.